Monday, November 17, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Financial Analyst Maintains Hold Rating for JDcom with Raised Price Target

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
Finance_Assets (3)
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

On March 11, 2024, financial analyst Rob Sanderson from Loop Capital decided to maintain a Hold rating for JD.com but raised the price target to $26. Despite this change, the overall consensus among analysts for JD.com remains a Moderate Buy, with an average price target of $36.88, indicating a potential increase of 41.03% from the current price. It is worth noting that Loop Capital had previously adjusted JD.com’s price target to $39 from $42 while still keeping a Hold rating in place.

JD Stock Shows Strong Performance with 6.08% Increase in Share Price on March 11, 2024

On March 11, 2024, JD stock showed some positive momentum as it saw a significant increase in its share price. The price of JD shares increased by $1.50 since the market last closed, representing a 6.08% increase. The stock opened at $25.60, which was $0.85 higher than its previous close. This opening price indicated a strong start for JD on that day, setting the stage for a positive trading session. Investors and analysts may have been encouraged by this price momentum and the positive movement seen in JD stock on March 11. The increase in share price could be attributed to a variety of factors, including market conditions, company performance, or investor sentiment. Overall, the performance of JD stock on March 11, 2024, demonstrated a positive trend with a notable increase in share price. Investors will continue to monitor the stock’s performance and market conditions to make informed decisions about their investment strategies.

JD Stock Performance Analysis: Revenue Holds Steady While Net Income and EPS Show Impressive Growth

On March 11, 2024, JD stock performance showed some interesting trends based on the latest financial data provided by CNN Money.

Total revenue for JD stood at $153.09 billion for the past year, with $42.34 billion in the fourth quarter. The total revenue has remained flat since last year and also since the last quarter. This indicates that JD has been able to maintain a consistent level of revenue over the past year.

Net income for JD was reported at $3.41 billion for the past year, with $468.83 million in the fourth quarter. The net income has increased by an impressive 121.28% since last year, showing that JD has been able to significantly improve its profitability. However, the net income has held flat since the last quarter.

Earnings per share (EPS) for JD were reported at $2.15 for the past year, with $0.30 in the fourth quarter. The EPS has increased by a substantial 121.98% since last year. However, the EPS has decreased by 57.13% since the last quarter.

Overall, the financial data for JD on March 11, 2024, shows a mixed performance with strong growth in net income and earnings per share over the past year, but some challenges in maintaining the same level of profitability in the most recent quarter. Investors will be closely watching JD’s future performance to see if the company can continue to grow its revenue and profitability.

Tags: JD
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Investor Sentiment and Options Trading Activity for Pfizer

Neurotechnology

Monolithic Power Systems MPWR A 15Year Success Story

Biotechnology Stock Market Today (1)

Anticipation Builds for BioXcel Therapeutics Earnings Report

Recommended

Biotechnology Stock Bull Market

Transcode Therapeutics Inc Follows Biopharmaceutical Trend with Public Offering of Common Stock

2 years ago
Flavors, Fragrances Stock

Flavors & Fragrances Stock: Can Strategic Moves Overcome Analyst Concerns?

1 month ago
Uranium Energy Stock

U.S. Nuclear Push Ignites Uranium Energy Shares

3 weeks ago
Nel ASA Stock

A Major Contract Fails to Lift Nel ASA’s Stock

1 week ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Beyond Meat Shares Plummet as Write-Off and Declining Sales Signal Deepening Crisis

XPeng Faces Critical Earnings Test Amid Soaring Expectations

Baidu’s AI Ambitions Face Earnings Test

Freeport-McMoRan’s Critical Juncture: Navigating Production Crisis and Legal Challenges

Tesla Gains Breathing Room in Critical Battery Supply Dispute

Johnson & Johnson Shares Approach Record Territory

Trending

CureVac Stock
Analysis

CureVac Shareholders Face Pivotal Takeover Vote

by Felix Baarz
November 17, 2025
0

The fate of German biotech firm CureVac hangs in the balance as shareholders prepare for a landmark...

DroneShield Stock

DroneShield Shares Stage Recovery Amid Governance Concerns

November 17, 2025
Metaplanet Stock

Metaplanet Shares Soar Amid Regulatory Scrutiny of Bitcoin Strategy

November 17, 2025
Beyond Meat Stock

Beyond Meat Shares Plummet as Write-Off and Declining Sales Signal Deepening Crisis

November 17, 2025
XPeng Stock

XPeng Faces Critical Earnings Test Amid Soaring Expectations

November 17, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • CureVac Shareholders Face Pivotal Takeover Vote
  • DroneShield Shares Stage Recovery Amid Governance Concerns
  • Metaplanet Shares Soar Amid Regulatory Scrutiny of Bitcoin Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com